Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

CATX
Perspective Therapeutics, Inc.
stock NYSEAMERICAN

At Close
May 8, 2025 3:59:57 PM EDT
2.41USD+2.553%(+0.06)557,327
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 8, 2025 9:18:30 AM EDT
2.37USD+0.851%(+0.02)8,461
After-hours
May 8, 2025 4:00:30 PM EDT
2.42USD+0.207%(+0.01)2,556
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
open chart   
open chart   
Market Cap
179.20M
Headquarters
Richland, Washington, USA
Industry
Medical Devices
Last Split
Jun 17, 20241for10reverse
CATX Stats
Avg. Vol. 10 Day
586,181
Avg. Vol. 30 Day
850,376
Employees
66
Market Cap
179,203,035
Shares Out.
74,050,841
On/Off Exchange
52%/48%
6 Month Beta
1.46
1 Year Beta
1.53
2 Year Beta
1.43
3 Year Beta
1.37
52 Week Low
1.60
52 Week High
19.05
SMA50
2.31
SMA200
7.23
1 Week
-2.02%
1 Month
+41.52%
3 Month
-26.89%
6 Month
-78.49%
1 Year
-86.25%
2 Year
-63.83%
Profile
the introduction of cesium-131 represents the culmination of decades of work and millions of dollars of investment. top medical centers, hospitals and clinics across the united states are now offering this breakthrough treatment for cancer patients. the word brachytherapy derives from the greek prefix brachy, meaning "short" or "close," because the titanium capsules containing the radioisotope are implanted directly into the cancerous prostate gland. treatment of cancer using low dose radiation or "seed" brachytherapy was pioneered in the 1960's as an effective alternative to radical prostatectomy. pioneers in brachytherapy research initially theorized about the use of cesium-131 in a titanium capsule, however scientific and economic limitations at the time prevented its development and iodine-125 emerged as an alternative. beginning in 1967, iodine-125 became the first radioisotope manufactured in a titanium capsule, or seed. while its use continues to this day, many patients and doct

CATX Stock Summary

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) stock price today is $2.41, and today's volume is 557,327. CATX is up 2.553% today. The 30 day average volume is 850,376. CATX market cap is 179.20M with 74,050,841 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC